We are live on ! Find out more
TGI

TRV GP II Portfolio holdings

AUM $1.34M
1-Year Est. Return 67.55%
This Fund
S&P 500
This Quarter Est. Return
+43.18%
1 Year Est. Return
-67.55%
3 Year Est. Return
-20.84%
5 Year Est. Return
-49.87%
10 Year Est. Return
–
AUM
$534M
AUM Growth
-$21.6M
Cap. Flow
-$191M
Cap. Flow %
-35.73%
Top 10 Hldgs %
100%
Holding
5
New
–
Increased
–
Reduced
2
Closed
–

Top Buys

No buys this quarter

Top Sells

Rank Stock Value
1
MYOK
MyoKardia, Inc. Common Stock
MYOK
+$104M
2
SAGE
Sage Therapeutics
SAGE
+$86.7M

Sector Composition

Rank Sector Weight
1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
JNCE
1
DELISTED
Jounce Therapeutics, Inc. Common Stock
JNCE
$229M 42.85%
10,230,349
– –
BPMC
2
DELISTED
Blueprint Medicines
BPMC
$225M 42.17%
2,453,753
– –
MYOK
3
DELISTED
MyoKardia, Inc. Common Stock
MYOK
$43.2M 8.09%
885,104
-2,000,000
-69% -$104M
ALNA
4
DELISTED
Allena Pharmaceuticals
ALNA
$30.8M 5.76%
2,790,964
– –
SAGE
5
DELISTED
Sage Therapeutics
SAGE
$6.02M 1.13%
37,362
-510,554
-93% -$86.7M

Similar funds

IVAV
Index Venture Associates V St. Helier, Channel Islands, Jersey $1.46M AUM 88.05% 1-Year Est. Return
VM
Value Monitoring Menlo Park, California $1.5M AUM 13.21% 1-Year Est. Return
CL
CRV LLC Palo Alto, California $1.56M AUM 87.36% 1-Year Est. Return
GAM
GVO Asset Management Zug, Switzerland $1.07M AUM 24.36% 1-Year Est. Return
MC
Manteio Capital Jersey City, New Jersey $1.05M AUM
NC
Noked Capital Tel Aviv, Israel $946K AUM 17.1% 1-Year Est. Return
HCIG
H Capital II GP Grand Cayman, Cayman Islands $1.83M AUM
NP
Nimble Partners San Francisco, California $556K AUM 61.7% 1-Year Est. Return

TRV GP II's Q1 2018 Portfolio in Review

As of Q1 2018, TRV GP II held 5 positions worth $534M, down 3.9% from $555M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

TRV GP II withdrew a net $191M in Q1 2018, reducing 2 holdings. Its largest reduction was MyoKardia, Inc. Common Stock, cutting an estimated $104M.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets, unchanged from a quarter earlier.

  • TRV GP II's biggest Q1 2018 reduction was MyoKardia, Inc. Common Stock, cutting an estimated $104M.
  • TRV GP II's ten largest holdings make up 100% of its $534M portfolio in Q1 2018.
  • TRV GP II opened 0 new positions and closed 0 in Q1 2018.
  • TRV GP II's portfolio value fell 3.9% quarter-over-quarter to $534M.

Based on TRV GP II's 13F filing for Q1 2018, filed 19 Apr 2018.